| (210) | Number of the EPO application | 16791713 |
| (220) | Filing date of the EPO application | 2016.10.07 |
| (80) | EPO patent specification publication (B) | EPB nr. 16/2023, 2023.04.19 |
| (110) | EPO patent number | 3359182 |
| (21) | Number of the application | e 2018 0800 |
| (71) | Name(s) of applicant(s), code of the country | Nektar Therapeutics, US; |
| (72) | Name(s) of inventor(s), code of the country | CHARYCH Deborah, US;
KIRK Peter, GB; |
| (73) | Name(s) of owner(s), code of the country | Nektar Therapeutics, US; |
| (54) | Title of the invention | COMBINATION OF AN IL-2RBETA-SELECTIVE AGONIST AND A LONG-ACTING IL-15 AGONIST |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 38/20 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.09.30 |
| (30) | Priority | 201562239207 P, 2015.10.08, US |
| (86) | International application | PCT/US2016/056088, 2016.10.07 |
| (87) | International publication | WO 2017/062832, 2017.04.13 |